Phio Pharmaceuticals Corp (PHIO) Social Stream



Phio Pharmaceuticals Corp (PHIO): $1.76

0.02 (+1.15%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add PHIO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#246 of 337

in industry

PHIO PHARMACEUTICALS CORP (PHIO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PHIO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2023-08-16 1 $6 $6 $6 $0.759 690.51%

Price Target Last Issued August 16, 2023

The Trend in the Analyst Price Target


PHIO's average price target has moved down $0 over the prior 23 months.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-08-16 1 6 6 6 2.21 171.49%

PHIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 21 months, PHIO's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how PHIO PHARMACEUTICALS CORP fares relative to all US stocks, note that its number of analysts covering the stock is higher than practically none of that group.
  • PHIO PHARMACEUTICALS CORP's variance in analysts' estimates is lower than nearly 100% of all US stocks.
  • In the context of Healthcare stocks, PHIO PHARMACEUTICALS CORP's average analyst price target is greater than 8.81% of them.
  • PHIO PHARMACEUTICALS CORP's upside potential (average analyst target price relative to current price) is higher than 86.85% of Healthcare stocks.

Stocks similar to PHIO PHARMACEUTICALS CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ORGS, EVOK, and NBY.

Is PHIO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!